Codes / ICD10CM / M02.261

M02.261 Postimmunization arthropathy, right knee

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Postimmunization arthropathy, right knee (ICD Code: M02.261)

Summary

Postimmunization arthropathy, right knee is a form of reactive arthritis affecting the right knee joint that develops following vaccination. The condition is characterized by joint inflammation and pain, typically occurring weeks to months after immunization. It is considered a post-vaccination complication linked to immune responses triggered by the vaccine, with symptoms localized to the right knee.

Causes

Postimmunization arthropathy, right knee is caused by the body's immune response to vaccination. The vaccine stimulates an inflammatory reaction that can affect joints, including the right knee, even after the initial immune response to the vaccine has resolved. The exact mechanism involves immune complex formation and systemic inflammation, though the precise pathways are not fully understood.

Risk Factors

  • History of vaccination, particularly with certain vaccines (e.g., live attenuated or adjuvanted vaccines).
  • Pre-existing joint conditions or autoimmune tendencies.
  • Genetic predisposition to inflammatory arthritis.
  • Delayed or inadequate monitoring after vaccination.

Symptoms

  • Joint pain, swelling, and stiffness in the right knee.
  • Reduced range of motion or difficulty moving the right knee.
  • Systemic symptoms like fever or malaise in some cases.
  • Symptoms typically develop weeks to months after vaccination.

Diagnosis

Diagnosis involves a clinical evaluation of symptoms, including joint pain and swelling in the right knee, and a history of recent vaccination. Laboratory tests may be used to rule out other causes of arthritis, such as infection or autoimmune disease. Imaging studies, like X-rays or MRI, can help assess joint damage or inflammation.

Treatment Options

Treatment focuses on reducing inflammation and managing pain. Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used to alleviate symptoms. In severe cases, corticosteroid injections or physical therapy may be recommended to improve joint function. Treatment is typically tailored to the severity of symptoms and response to initial interventions.

Prognosis and Follow-Up

Most cases of postimmunization arthropathy, right knee, resolve with appropriate treatment within weeks to months. However, some individuals may experience persistent symptoms or recurrent episodes. Regular follow-up with a healthcare provider is important to monitor joint function and adjust treatment as needed.

Complications

Potential complications include chronic joint pain, reduced mobility, or long-term joint damage if left untreated. Rarely, the condition may progress to a more severe form of arthritis. Early diagnosis and treatment can help minimize these risks.

Lifestyle & Prevention

  • Avoid strenuous activities that加重 joint pain until symptoms improve.
  • Apply ice or heat to the right knee to reduce inflammation and pain.
  • Maintain a healthy weight to reduce stress on the knee joint.
  • Follow vaccination guidelines and report any joint symptoms to a healthcare provider promptly after immunization.

When to Seek Professional Help

Seek medical attention if joint pain or swelling in the right knee persists or worsens, or if systemic symptoms like fever develop. Prompt evaluation is important to rule out other serious conditions and initiate appropriate treatment.

Tips for Medical Coders

When coding for postimmunization arthropathy, right knee (M02.261), ensure documentation specifies the right knee as the affected site and links the condition to a recent vaccination. Include details such as symptom onset, duration, and any diagnostic tests or treatments provided to support the code assignment.

Book a walkthrough

M02.261 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.